NCT05872854 2026-02-09RW-HPN-MF-01Abramson Cancer Center at Penn MedicinePhase 2 Completed10 enrolled
NCT04447027 2026-01-30Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell MalignanciesNational Institutes of Health Clinical Center (CC)Phase 1 Completed26 enrolled 24 charts